Avidity Biosciences
RNAM
#1794
Rank
HK$88.15 B
Marketcap
HK$570.66
Share price
0.00%
Change (1 day)
117.02%
Change (1 year)

Market capitalization of Avidity Biosciences (RNAM)

Market cap: HK$88.15 Billion

As of March 2026 Avidity Biosciences has a market cap of HK$88.15 Billion. This makes Avidity Biosciences the world's 1794th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences in 2026

End of year Market Cap

Year Marketcap Change
2026HK$88.15 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
HK$1.209 T 1,272.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$840.32 B 853.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
HK$14.14 B-83.96%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
HK$44.10 B-49.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
HK$1.04 B-98.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
HK$6.43 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
HK$85.66 B-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
HK$22.44 B-74.54%๐Ÿ‡บ๐Ÿ‡ธ USA